Prostate Cancer - Results from #200

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer. April 27, 2023

Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging. April 27, 2023

Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State. April 27, 2023

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. April 26, 2023

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy. April 26, 2023

Mental wellbeing and quality of life in prostate cancer (MIND-P): Protocol for a multi-institutional prospective cohort study. April 26, 2023

Associations Between Intraductal Prostate Cancer and Metastases Following Radical Prostatectomy in Men With Prostate Cancer in the Veterans Affairs Database. April 26, 2023

Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023). April 26, 2023

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer. April 25, 2023

African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. April 25, 2023

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer. April 25, 2023

Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling. April 25, 2023

The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery. April 25, 2023

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel. April 25, 2023

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer. April 25, 2023

Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. April 25, 2023

ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer. April 25, 2023

Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer April 24, 2023

Accumulation of copy number alterations and clinical progression across advanced prostate cancer. April 24, 2023

Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data. April 24, 2023

Page 11 of 1306